More than half of Americans have reported medical debt of some kind, lamenting that it affects other financial goals. As a result, many are delaying care. So it’s not surprising that employers, with the guidance and support of their benefit brokers, have been trying virtually every trick in the book to control costs — with little to no avail.
Some will claim that they have slayed this high-cost dragon, but I would argue that they have not, because most cost-savings solutions are only treating symptoms and not the disease. Individual short-term wins at controlling costs do not have any impact on the system as a whole, leaving the majority of Americans struggling.
